Once the conclusion about dopamine receptors having an involvement in schizophrenic patients was established; the serotonin levels in schizophrenic patients was also observed. Advokat, Comaty, and Julien explain that it was observed that serotonin wasn’t involved in triggering schizophrenia; however, it did trigger side effects involving the medications prescribed to schizophrenic patients. Schizophrenic patients were prescribed neuroleptics, specifically the prescription of Thorazine. In Whitaker’s Anatomy of an Epidemic it explains, “The neuroleptics did help reduce some target symptoms-unrealistic thinking, anxiety, suspiciousness, auditory hallucinations, etc.-better than the placebo, and thus, according to the rating’s scales cumulative
